|
ANAPC10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.80688797257744E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.4580006353101E-11 |
| Normal-vs-Stage2 |
4.04639999951328E-07 |
| Normal-vs-Stage3 |
1.83499992978398E-10 |
| Normal-vs-Stage4 |
9.2361673864616E-12 |
| Stage1-vs-Stage2 |
4.907800E-01 |
| Stage1-vs-Stage3 |
1.465410E-01 |
| Stage1-vs-Stage4 |
6.157600E-03 |
| Stage2-vs-Stage3 |
7.410800E-01 |
| Stage2-vs-Stage4 |
2.400200E-01 |
| Stage3-vs-Stage4 |
2.702800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.04249942012302E-13 |
| Normal-vs-AfricanAmerican |
7.479400E-03 |
| Normal-vs-Asian |
2.36410000464815E-08 |
| Caucasian-vs-AfricanAmerican |
5.271800E-02 |
| Caucasian-vs-Asian |
9.839000E-01 |
| AfricanAmerican-vs-Asian |
8.503700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.86073378927176E-13 |
| Normal-vs-Female |
2.09779971171997E-11 |
| Male-vs-Female |
9.634100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.1257999783848E-09 |
| Normal-vs-Age(41-60Yrs) |
1.15429887870278E-12 |
| Normal-vs-Age(61-80Yrs) |
8.66670069044062E-11 |
| Normal-vs-Age(81-100Yrs) |
2.060100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.002200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.137900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.115600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.083000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.548000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.572800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.850200E-02 |
| Classical-VS-Follicular |
5.180400E-01 |
| Classical-VS-Other |
6.551600E-01 |
| Classical-VS-Normal |
1.14700471343099E-11 |
| Tall-VS-Follicular |
2.693800E-01 |
| Tall-VS-Other |
5.905800E-01 |
| Tall-VS-Normal |
6.42949999907216E-08 |
| Follicular-VS-Other |
8.852800E-01 |
| Follicular-VS-Normal |
1.45330000034249E-07 |
| Other-VS-Normal |
7.604000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.36110020424007E-11 |
| Normal-vs-N1 |
2.54380000397347E-08 |
| N0-vs-N1 |
8.084000E-01 |
|
|
